Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Risk Assessment of ZnO Nanoparticles Revelation on Erythrocyte Membrane


Affiliations
1 Department of pharmaceutical Biotechnology, Srikrupa Institute of Pharmaceutical Sciences, Siddipet, Medak, Telungana, India
2 Department of Pharmacology, SSM College of pharmacy, Zambai, Erode, Tamil Nadu, India
3 Department of Pharmaceutics, GITAM University, Rushikonda, Visakapatnam, Andhra Pradesh, India
     

   Subscribe/Renew Journal


Rapid developments in the cosmetics, food and drug applications Zinc oxide (ZnO) nano materials have resulted in concerns related to the risk of overexposure of human blood. The rationale of this study was to systematically research the influence of nano-ZnO on erythrocyte. The ZnO nanoparticle was prepared by sol-gel method with size of 40 ± 5 nm. The erythrocytes treated with nano-ZnO underwent abnormal sedimentation, aggregation along with dose dependent haemolysis. The ghost cells were investigated by using ultrathin cell section in the case under nano-ZnO. The RBC membrane destruction further confirmed by malondialdehyde (MDA) quantification. The results imply better understanding of the interaction between erythrocytes and nano-ZnO and will help in assessing the risk of nanomaterial toxicity in blood that may have potential toxicity to human being health. The following results suggest that the risk assessment of nano-materials and nano-products should be carried out prior to their wide application although they hold much more inconceivable and remarkable advantages.

Keywords

Zinc Oxide Nanoparticles, Erythrocyte, Nanotoxicity.
User
Subscription Login to verify subscription
Notifications
Font Size

  • Vyom Sharma, Poonam Singh, Alok K. Pandey, Alok Dhawan, Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutation Res 2012; 745: 84-91.
  • Gerloff K, Albrecht C, Boots A.W, Forster I, Schins R.P.F, Cytotoxicity and oxidative DNA damage by nanoparticles in human intestinal Caco-2 cells. Nanotoxicol 2009; 3: 355364.
  • Jin T, Sun D, Su J.Y, Zhang H, Sue H.J, Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella enteritidis, and Escherichia coli. Food Sci 2009; 74: 46-52.
  • Rasmussen J.W, Martinez E, Louka P, Wingett D.G, Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin. Drug Deliv 2010; 7: 1063-1077.
  • Miller R.J, Lenihan H.S, Muller E.B, Seng N.T, Hanna, S.K, Keller A.A, Impacts of metal oxide nanoparticles on marine phytoplankton. Environ. Sci. Technol 2003; 44: 7329-7334.
  • Gojova A, Guo B, Kota R.S, Rutledge J.C, Kennedy I.M, Barakat A.I, Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: of particle composition. Environ. Health Perspect 2007; 115: 403-409.
  • Wang H.J, Growcock A.C, Tang T.H, Hara J.O, Huang Y.W, Aronstam R.S, Zinc oxide nanoparticle disruption of storeoperated calcium entry in a muscarinic receptor signaling pathway. Toxicol. In Vitro 2010; 24: 1953-1961.
  • Kwon Y.J, Kim H.K, Lim C.S, Shim K.B, Characterization of ZnO nanopowders synthesized by the polymerized complex method via an organochemical route. J Ceramic Processing Res 2002; 3: 146-149.
  • Shi-Qiang Li, Rong-Rong Zhu, Hong Zhu, Meng Xue, XiaoYu Sun, Si-De Yao, Shi-Long Wang, Nanotoxicity of TiO2 nanoparticles to erythrocyte in vitro. Food Chem Toxicol 2008; 46: 3626-3631.
  • Rothen-Rutishauser B.M, Schurch S, Haenni B, Kapp N, Gehr P, Interaction of fine and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol 2006; 40: 4353-4359.
  • Katsu T, Kuroko M, Morikawa T, Mechanism of membrane damage induced by the amphipatic peptides gramicidin S and melittin. Biochim. Biophys. Acta 1989; 983: 135-141.
  • Scott, M.D, Van den berg, J.J, Repka, T, Rouyer-Fessard, P, Hebbel, R.P, Lubin, B.H, Effect of excess alpha-haemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest 1993; 91: 1706-1712.
  • Carpentier P.H, Imbert B, Picart C, Brasseur S, Malterre C, Morphometric analysis of erythrocyte aggregates in vitro: pharmacological application with buflomedil. J Mal Vasc 2000; 25: 356-359.
  • Prasanthi K, Muralidhara Rajini, P.S, Morphological and biochemical perturbations in rat erythrocytes following in vitro exposure to Fenvalerate and its metabolite. Toxicol In vitro 2005; 19: 449-456.
  • Min Jung Kim, Sehyun Shin, Toxic effects of silver nanoparticles and nanowires on erythrocyte rheology. Food Chem Toxicol 2014; 67: 80-86.
  • Agroyannis B, Dalamangas A, Tzanatos H, Fourtounas C, Kopelias I, Konstadinidou I, Koutsikos D, Are alterations of protein 4.1 involved in the echinocytic transformation of red blood cells. Blood 1994; 84: 1685-1686.
  • Asharani P.V, Sethu S, Vadukumpully S, Zhong S, Lim C.T, Hande M.P, Valiyaveettil S, Investigations on the structural damage in human erythrocytes exposed to silver, gold, and platinum nanoparticles. Adv. Funct. Mater. 2010; 20: 1233-1242.
  • Choi J.H, Reipa V, Hitchins V.M, Goering P.L, Malinauskas R.A, Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci 2011; 123: 133-143.
  • Shin S, Ku Y.H, Ho J.X, Kim Y.K, Suh J.S, Singh M, Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. Clin. Hemorheol. Microcirc 2007; 36: 253-261.
  • Duchnowicz, P, Koter, M, Duda W, Damage of erythrocyte by phenoxyacetic herbicides and their metabolites. Pestic. Biochem. Physiol 2002; 74: 1-7.
  • Hebbel R.P, Leung A, Mohandas N, Oxidation-induced changes in microrheologic properties of the red blood cell membrane. Blood 1990; 76: 1015-1020.
  • John S, Marpu S, Li J, Omary M, Hu Z, Fujita Y, Neogi A, Hybrid zinc oxide nanoparticles for biophotonics. J Nanosci Nanotechnol 2010; 10: 1707-1712.
  • Tran C.L, Buchanan D, Cullen R.T, Searl A, Jones A.D, Donaldson K, Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 2000; 12: 1113-1126.

Abstract Views: 440

PDF Views: 0




  • Risk Assessment of ZnO Nanoparticles Revelation on Erythrocyte Membrane

Abstract Views: 440  |  PDF Views: 0

Authors

Santhosh Kumar Chinnaiyan
Department of pharmaceutical Biotechnology, Srikrupa Institute of Pharmaceutical Sciences, Siddipet, Medak, Telungana, India
Mohan Raj Subramanian
Department of Pharmacology, SSM College of pharmacy, Zambai, Erode, Tamil Nadu, India
Venkata Radha Gadela
Department of Pharmaceutics, GITAM University, Rushikonda, Visakapatnam, Andhra Pradesh, India

Abstract


Rapid developments in the cosmetics, food and drug applications Zinc oxide (ZnO) nano materials have resulted in concerns related to the risk of overexposure of human blood. The rationale of this study was to systematically research the influence of nano-ZnO on erythrocyte. The ZnO nanoparticle was prepared by sol-gel method with size of 40 ± 5 nm. The erythrocytes treated with nano-ZnO underwent abnormal sedimentation, aggregation along with dose dependent haemolysis. The ghost cells were investigated by using ultrathin cell section in the case under nano-ZnO. The RBC membrane destruction further confirmed by malondialdehyde (MDA) quantification. The results imply better understanding of the interaction between erythrocytes and nano-ZnO and will help in assessing the risk of nanomaterial toxicity in blood that may have potential toxicity to human being health. The following results suggest that the risk assessment of nano-materials and nano-products should be carried out prior to their wide application although they hold much more inconceivable and remarkable advantages.

Keywords


Zinc Oxide Nanoparticles, Erythrocyte, Nanotoxicity.

References





DOI: https://doi.org/10.22506/ti%2F2017%2Fv24%2Fi1%2F149039